CAS RN: 23194-93-6
5,6-Dihydrodibenzo[b,f]azocine
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250825 |
100mg / 250mg / 1g / 5g / 25g / 100g |
Confirm by inquiry |
Shandong, Shanghai | 8-10 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 10g, 25g, 1g, 100g, 0.25g, 5g
- Available purity: >98%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 23194-93-6
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 10g |
>98% |
3
In Stock
|
Shenzhen |
Inquiry |
| 25g |
>98% |
3
In Stock
|
Beijing |
Inquiry |
| 1g |
>98% |
2
In Stock
|
Beijing |
Inquiry |
| 100g |
>98% |
1
In Stock
|
Beijing |
Inquiry |
| 0.25g |
>98% |
0
Out of Stock
|
Shanghai |
Inquiry |
| 5g |
>98% |
0
Out of Stock
|
Hong Kong |
Inquiry |
23194-93-6 / (11Z)-5,6-dihydrobenzo[c][1]benzazocine
Standard CAS: 23194-93-6
Multi CAS: No
Basic Information
CAS
23194-93-6
Multi CAS
No
Molecular Formula
C15H13N
Molecular Weight
207.270000
Exact Mass
207.104799
SMILES
C1C2=CC=CC=C2/C=C\C3=CC=CC=C3N1
InChI
InChI=1S/C15H13N/c1-2-7-14-11-16-15-8-4-3-6-13(15)10-9-12(14)5-1/h1-10,16H,11H2/b10-9-
InChIKey
ROKWPTFIJIFMGL-KTKRTIGZSA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Aromatic heavy atom count
12
Fraction Csp3
0.07
H-bond acceptors
1
H-bond donors
1
Molar refractivity
69.14
TPSA
12.03
LogP / Solubility
WLOGP
3.78
MLOGP
3.33
XLogP3
3.4
Consensus LogP
3.5
Log S (ESOL)
-4.06
Class (ESOL)
Slightly soluble
Log S (Ali)
-3.99
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.15
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.3
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5